(Q34723678)

4 August 2017

title

Barriers to the treatment of hepatitis C. Patient, provider, and system factors (English)

1 reference

4 August 2017

1 reference

James A Morrill

1

1 reference

4 August 2017

Melissa Shrestha

series ordinal

2

1 reference

4 August 2017

Richard W Grant

series ordinal

3

1 reference

4 August 2017

publication date

1 August 2005

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

20

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

754-758

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1525-1497.2005.0161.x

4 August 2017

exact match

0 references

cites work

Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Impact of population management with direct physician feedback on care of patients with type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Chronic Hepatitis C Virus Infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Understudied populations with hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Limited success of HCV antiviral therapy in United States veterans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

The alcoholic patient with hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Directly observed therapy in an inner city hospital.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Treatment of chronic hepatitis C in a state correctional facility

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Treatment of hepatitis C infection in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Treating hepatitis C in methadone maintenance patients: an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Screening for hepatitis C virus infection in adults: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Treatment of chronic hepatitis C in active drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Helping the urban poor stay with antiretroviral HIV drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1497.2005.0161.X

Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490173

Management of hepatitis C

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16050887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1525-1497.2005.0161.X

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference